Sector portfolio · Private equity · United States

Invus' Biotech portfolio

Invus has backed 50 Biotech startups in rounds we track, $9.0B between them, shown by the stage each has reached. The best-funded is Erasca.

50startups backed
4stages
$9.0Braised between them
Stage not reportedbiggest stage

Invus's whole portfolioInvus's profile

Stage not reported

16

Series B

14

Series A

10

Series C and later

10

Segment by segment

Stage not reported

16 startups · $2.2B raised

  1. Tyra BiosciencesTyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.United States$600M
  2. Leyden LabsLeyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions foNetherlands$221M
  3. SchrödingerSchrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotecUnited States$195M
  4. Cartesian TherapeuticsPioneering Potent, Safer Cell Therapy in and Beyond OncologyUnited States$180M
  5. Kaleido BioSciencesKaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.United States$161M
  6. LEXEO TherapeuticsLEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases.United States$154M
  7. Ablative SolutionsAblative Solutions is a clinical-stage medical device company founded in 2011, based in Wakefield, Massachusetts.United States$130M
  8. PatientsLikeMePatientsLikeMe is a leading personalized health network and digital health management platform.United States$127M

Series B

14 startups · $2.9B raised

  1. BBioNTechGermany$687M
  2. LarondeLaronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.United States$440M
  3. CTCity TherapeuticsUnited States$235M
  4. Matchpoint TherapeuticsMatchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021.United States$220M
  5. Osanni BioOsanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases.United States$190M
  6. Repertoire Immune MedicinesRepertoire Immune Medicines is a clinical stage biotechnology company.-$189M
  7. SepternaSepterna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases.United States$150M
  8. MOMA TherapeuticsMOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$150M

Series A

10 startups · $1.7B raised

  1. ErascaErasca is a developer of oncology drugs intended to provide precision oncology options.United States$739M
  2. Morphic TherapeuticMorphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases.United States$328M
  3. Averna TherapeuticsAverna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.United States$170M
  4. Ottimo PharmaOttimo Pharma is a private, clinical-stage biotechnology company based in Sandwich, Kent, United Kingdom.United Kingdom$140M
  5. Kronos BioKronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer.United States$123M
  6. Exsilio TherapeuticsExsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA.-$82M
  7. Faze MedicinesFaze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020.United States$81M
  8. Triplet TherapeuticsTriplet Therapeutics develops and commercializes ribonucleic acid targeted therapeutics for the treatment of Huntington's disease.United States$49M

Series C and later

10 startups · $2.2B raised

  1. Arcus BiosciencesArcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.United States$427M
  2. Encoded TherapeuticsEncoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies.United States$379M
  3. Solid BiosciencesSolid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.United States$333M
  4. MetacrineMetacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs.United States$173M
  5. Rani TherapeuticsRani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes.United States$168M
  6. HemabHemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.Denmark$157M
  7. KSQ TherapeuticsKSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.United States$156M
  8. Lyndra TherapeuticsLyndra Therapeutics is a clinical-stage biopharmaceutical company based in Watertown, Massachusetts.United States$156M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Invus as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Portfolio mapInvus portfolio map69 startups · $18BCo-investorsWho invests with Invus65 co-investorsSector portfolioRA Capital Management's Biotech portfolio197 startups · $38BSector portfolioOrbiMed's Biotech portfolio176 startups · $28BSector portfolioPioneer Fund's AI portfolio171 startups · $2.8BSector portfolioGaingels' AI portfolio146 startups · $14B

Raising from investors like Invus?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps